Cian Healthcare Ltd

Cian Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Cian Healthcare Ltd

₹ 5.01 1.83%
20 Jan 2026
cian.co BSE - SME: 542678
About

Incorporated in 2003, Cian Healthcare Ltd is engaged in manufacturing and marketing of pharmaceutical products.[1]

Key Points

Business Overview:[1][2]
CHI is a fully integrated pharmaceutical company dealing in gynecology, hematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotic, CNS, vitamins & nutrient products.

Website BSE
  • Market Cap ₹ 12.5 Cr.
  • Current Price ₹ 5.01
  • High / Low ₹ 7.66 / 2.99
  • Stock P/E
  • Book Value ₹ 15.2
  • Dividend Yield 0.00 %
  • ROCE -5.70 %
  • ROE -14.3 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.33 times its book value
  • Promoter holding has increased by 67.9% over last quarter.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -11.6% over past five years.
  • Company has a low return on equity of -3.43% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 184 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2019 Mar 2020 Sep 2020 Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025
29.41 27.63 38.54 33.84 37.01 27.10 34.84 32.72 30.61 28.14 18.55 12.34 11.32
26.19 23.30 33.79 29.26 35.52 23.65 31.57 27.54 28.40 22.99 18.56 15.36 15.00
Operating Profit 3.22 4.33 4.75 4.58 1.49 3.45 3.27 5.18 2.21 5.15 -0.01 -3.02 -3.68
OPM % 10.95% 15.67% 12.32% 13.53% 4.03% 12.73% 9.39% 15.83% 7.22% 18.30% -0.05% -24.47% -32.51%
0.13 0.66 -0.12 0.12 0.06 0.34 0.41 0.17 0.89 0.17 -11.99 -0.01 0.63
Interest 2.93 2.88 2.83 3.38 2.64 2.50 2.38 1.80 2.41 2.32 1.98 0.06 0.00
Depreciation 1.61 0.85 1.23 1.22 1.28 1.29 1.82 1.83 1.84 1.85 1.54 1.06 1.06
Profit before tax -1.19 1.26 0.57 0.10 -2.37 0.00 -0.52 1.72 -1.15 1.15 -15.52 -4.15 -4.11
Tax % 0.00% 11.90% 35.09% 140.00% -0.42% -48.08% 21.51% 6.96% -23.48% 0.00% -0.48% 1.70%
-1.19 1.11 0.37 -0.04 -2.37 0.10 -0.27 1.35 -1.23 1.43 -15.52 -4.14 -4.19
EPS in Rs -0.51 0.48 0.16 -0.02 -1.01 0.04 -0.11 0.54 -0.49 0.57 -6.21 -1.66 -1.68
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
22.60 30.93 46.68 51.78 65.90 62.44 57.05 72.38 64.10 67.56 58.75 30.88 23.66
19.05 26.02 39.08 41.68 52.93 54.54 49.34 62.86 59.06 58.50 51.19 33.79 30.36
Operating Profit 3.55 4.91 7.60 10.10 12.97 7.90 7.71 9.52 5.04 9.06 7.56 -2.91 -6.70
OPM % 15.71% 15.87% 16.28% 19.51% 19.68% 12.65% 13.51% 13.15% 7.86% 13.41% 12.87% -9.42% -28.32%
0.14 0.21 0.47 0.07 0.18 0.95 0.72 0.00 0.40 0.57 1.06 -12.00 0.62
Interest 1.25 1.48 3.98 5.14 5.94 5.52 5.90 6.40 5.25 4.79 4.93 2.16 0.06
Depreciation 0.16 0.88 1.93 1.95 1.95 2.39 2.45 2.45 2.57 3.64 3.68 2.61 2.12
Profit before tax 2.28 2.76 2.16 3.08 5.26 0.94 0.08 0.67 -2.38 1.20 0.01 -19.68 -8.26
Tax % 32.46% 32.25% 28.70% 24.68% 23.95% 30.85% 187.50% 50.75% -4.20% 10.00% -3,800.00% -0.10%
1.54 1.86 1.55 2.31 4.00 0.66 -0.07 0.33 -2.28 1.08 0.39 -19.66 -8.33
EPS in Rs 154.00 186.00 110.71 165.00 285.71 0.38 -0.03 0.14 -0.91 0.43 0.16 -7.87 -3.34
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 0%
5 Years: -12%
3 Years: -22%
TTM: -49%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -299%
Stock Price CAGR
10 Years: %
5 Years: -15%
3 Years: -43%
1 Year: 50%
Return on Equity
10 Years: 0%
5 Years: -3%
3 Years: -3%
Last Year: -14%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 1.00 1.00 1.40 1.40 1.40 17.14 23.36 23.36 25.00 25.00 25.00 25.00 25.00
Reserves 5.37 7.23 9.58 11.89 16.34 4.56 36.19 36.51 35.35 36.43 36.82 17.16 12.97
15.96 32.00 31.06 39.68 50.41 48.66 51.22 49.30 43.08 42.71 41.01 39.99 39.99
3.79 6.09 14.78 8.31 8.42 21.66 23.92 25.47 36.36 36.49 40.06 60.53 57.34
Total Liabilities 26.12 46.32 56.82 61.28 76.57 92.02 134.69 134.64 139.79 140.63 142.89 142.68 135.30
2.50 19.40 18.14 21.48 20.00 23.48 20.78 18.73 32.82 29.42 25.88 23.32 22.29
CWIP 9.71 4.78 5.38 3.69 6.56 6.37 24.80 25.71 13.00 13.89 14.70 15.07 15.07
Investments 0.00 0.00 0.00 0.00 0.00 0.00 7.09 7.09 7.09 7.09 7.09 7.09 7.09
13.91 22.14 33.30 36.11 50.01 62.17 82.02 83.11 86.88 90.23 95.22 97.20 90.85
Total Assets 26.12 46.32 56.82 61.28 76.57 92.02 134.69 134.64 139.79 140.63 142.89 142.68 135.30

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.00 0.00 9.89 6.03 7.74 12.80 -9.24 5.46 5.51 2.15 6.94 20.66
0.00 0.00 -5.08 -4.02 -2.69 -8.32 -25.16 -1.20 -3.85 -1.08 -0.93 -0.27
0.00 0.00 -4.74 -1.51 -5.53 -2.74 35.09 -5.07 -2.65 -1.17 -6.41 -3.46
Net Cash Flow 0.00 0.00 0.07 0.50 -0.48 1.74 0.69 -0.81 -0.99 -0.10 -0.40 16.93
Free Cash Flow 0.00 0.00 9.09 2.97 4.81 7.09 -34.51 4.14 1.57 1.02 5.98 20.25
CFO/OP 0% 0% 138% 63% 60% 162% -120% 57% 109% 24% 92% -710%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 121.29 115.88 95.47 96.85 141.62 129.89 127.64 93.49 103.98 127.18 113.69 183.68
Inventory Days 169.27 158.62 137.27 127.72 160.45 144.03 214.22 218.69 324.72 310.27 404.15 460.88
Days Payable 60.32 70.56 122.04 20.77 53.01 143.67 173.70 150.64 274.80 210.62 269.65 609.29
Cash Conversion Cycle 230.24 203.94 110.70 203.81 249.07 130.25 168.16 161.54 153.90 226.83 248.20 35.27
Working Capital Days 55.88 51.57 16.65 40.32 56.27 44.19 5.31 12.15 60.93 49.27 48.89 -570.67
ROCE % 20.16% 13.55% 14.93% 17.30% 18.49% 9.39% 6.68% 6.61% 2.77% 5.74% 4.77% -5.70%

Insights

In beta
Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Total Permanent Employees
Number

Log in to view insights

Please log in to see hidden values.

Login
Actual Production Volume - Capsules
Lakhs Nos.
Actual Production Volume - Tablets
Lakhs Nos.
Installed Capacity - Capsules
Lakhs Nos.
Installed Capacity - Tablets
Lakhs Nos.
Total Product Registrations
Number
Total Product Units Manufactured
Units
Export Registrations Pipeline
Number

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Sep 2022Dec 2022Mar 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Sep 2025Mar 2026
66.26% 66.26% 66.26% 66.26% 51.85% 49.62% 27.10% 27.10% 27.11% 27.11% 27.11% 95.00%
0.00% 0.00% 0.00% 0.79% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
33.74% 33.74% 33.75% 32.96% 48.16% 50.39% 72.90% 72.90% 72.90% 72.89% 72.89% 5.01%
No. of Shareholders 3963924244184546728808311,0881,5011,6621,699

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings